April 3, 2019
AgomAb Therapeutics Completes Euros 21m Series A Financing
EUR 21m Series A secured with international investor syndicate co-led by V-Bio Ventures (Belgium) and Advent France Biotechnology (France), and…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
April 2, 2019
FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients
Successful manufacturing and release of GMP vials of UCARTCS1 NEW YORK–(BUSINESS WIRE)–Regulatory News: Cellectis (Euronext Growth: ALCLS – Nasdaq: CLLS),…
April 2, 2019
FDA issues three warning letters to companies dealing with cannabis related products
In a statement from the US FDA commissioner, the FDA on Tuesday said it has issued warning letters, in collaboration with the Federal Trade Commission, to three companies – Advanced Spine and Pain LLC (d/b/a Relievus), Nutra Pure LLC and PotNetwork Holdings Inc. – in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.
April 2, 2019
A New Corporate Image for AmorChem
MONTREAL–(BUSINESS WIRE)–AmorChem, a leading venture fund dedicated to creating the next generation of biotech companies derived from academic research, introduced…
April 2, 2019
Bristol-Myers Squibb Announces Long-Term Survival Results from Pooled Analyses of Opdivo (nivolumab) in Previously-Treated Non-Small Cell Lung Cancer Patients
Analyses include the longest follow-up of lung cancer patients treated with Immuno-Oncology therapy in phase 3 randomized trials PRINCETON, N.J.–(BUSINESS…
April 2, 2019
Bio-Rad Names Ilan Daskal Executive Vice President and Chief Financial Officer
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
April 2, 2019
Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®
MALVERN, Pa.–(BUSINESS WIRE)–Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well…
April 2, 2019
QUE Oncology Launches Phase II Trials in the United States
Biotech creating a new therapy for hot flashes in breast cancer patients launches clinical trials across United States ATLANTA–(BUSINESS WIRE)–Clinical…
April 2, 2019
Centogene names new board members
Centogene has appointed Dr. Flemming Ornskov to the Supervisory Board and he has also been elected Non-Executive Chairman, effective April 1, 2019.
April 2, 2019
Johnson & Johnson buy Auris Health for $3.4B, plus milestons payments
Johnson & Johnson has bought Auris Health, Inc. for about $3.4 billion in cash, with additional payments of up to $2.35 billion, in the aggregate, which may be payable upon reaching certain predetermined milestones, JJ said in a statement Monday.